Irregularities of Coagulation in Hypertension

Area of Science:

• Cardiovascular Medicine
• Hematology
• Pathophysiology

Background:

• Hypertension is a complex condition with multifactorial origins.
• The role of the coagulation system in hypertension pathogenesis is increasingly recognized.
• Understanding these links is crucial for developing novel therapeutic strategies.

Purpose of the Study:

• To review the critical role of coagulation factors in the development of hypertension.
• To summarize key coagulation markers and their association with hypertensive disease.
• To highlight potential biomarkers for hypertension and its complications.

Main Methods:

• Literature review of studies investigating coagulation markers in hypertension.
• Analysis of data linking specific coagulation factors (e.g., D-dimer, fibrinogen, P-selectin) to blood pressure and disease progression.
• Synthesis of findings on the pathophysiological mechanisms involved.

Main Results:

• Elevated D-dimer and fibrinogen levels correlate with hypertension severity and duration.
• Prothrombin time and activated partial thromboplastin time increase with blood pressure.
• Platelet activation markers (P-selectin, β-thromboglobulin) and endothelial markers (soluble urokinase plasminogen activator receptor, thrombomodulin) are implicated.
• Tissue factor and von Willebrand factor show potential as biomarkers for specific hypertensive conditions.

Conclusions:

• Coagulation factors, including D-dimer, fibrinogen, prothrombin, P-selectin, soluble urokinase plasminogen activator receptor, thrombomodulin, tissue factor, tissue plasminogen activator, and von Willebrand factor, are significantly involved in hypertension pathogenesis.
• These markers may serve as indicators of disease severity, duration, and potential complications.
• Further research into coagulation pathways could offer new avenues for hypertension management.